Improvement of the efcacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma hsc-4

Acta Medica Okayama

Volumn 67, Issue 3, 2013, Pages 153-164

  Yamamotoarf, Masanao ^a,c   Fujitaa, Hirofumi ^a   Katase, Naoki ^a   Inouec, Keiji ^b   Nagatsuka, Hitoshi ^a   Utsumi, Kozo ^a   Sasaki, Junzo ^a   Ohuchi, Hideyo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

Author keywords

5 aminolevulinic acid; Apoptosis; Oncology; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; AMINOLEVULINIC ACID; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; DEFEROXAMINE; FERROCHELATASE; PEPTIDE CHLOROMETHYL KETONE; PHOTOSENSITIZING AGENT; PLASMA PROTEIN; PROTOPORPHYRIN; SIDEROPHORE; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETICS; HUMAN; LIPID PEROXIDATION; METABOLISM; METHODOLOGY; MOUTH TUMOR; PATHOLOGY; PHOTOCHEMOTHERAPY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AMINO ACID CHLOROMETHYL KETONES; AMINOLEVULINIC ACID; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD PROTEINS; CARCINOMA, SQUAMOUS CELL; CASPASE INHIBITORS; CELL LINE, TUMOR; DEFEROXAMINE; FERROCHELATASE; GENE SILENCING; HUMANS; LIPID PEROXIDATION; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SIDEROPHORES;

EID: 84883177989     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Collaud S, Juzeniene J, Morn J and Lange N: On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr Med Chem Anticancer Agents (2004) 4: 301-316.
2. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE and Nesland JM: 5-Aminolevulinic acid-based photodynamic ther¬apy. Clinical research and future challenges. Cancer (1997) 79 2282-2308.
3. Hinnen P, DE Rooij FW, VAN Velthuysen ML, Edixhoven A, van Hillegersberg R, Tilanus HW, Wilson JH and Siersema PD Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre) malignant lesions of the oesophagus. Br J Cancer (1998) 78: 679-682
4. Bartosová J and Hrkal Z: Accumulation of protoporphyrin-IX (PplX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA). Comp Biochem Physiol C Toxicol Pharmacol (2000) 126 245-252.
5. Konopka K and Goslinski T: Photodynamic therapy in dentistry. J Dent Res (2007) 86: 694-707.
6. Uekusa M, Omura K, Nakajima Y, Hasegawa S, Harada H Morita Kl and Tsuda H: Uptake and kinetics of 5-aminolevulinic acid in oral squamous cell carcinoma. Int J Oral Maxillofac Surg (2010) 39: 802-805.
7. Krieg RC, Fickweiler S, Wolfbeis OS and Knuechel R: Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem Photobiol (2000) 72: 226-233.
8. Gibson SL, Havens JJ, Metz L and Hilf R: Is delta-aminolevulinic acid dehydratase rate limiting in heme biosynthesis following expo¬sure of cells to delta-aminolevulinic acid?. Photochem Photobiol (2001) 73: 312-317.
9. Ickowicz Schwartz D, Gozlan Y, Greenbaum L, Greenbaum L Babushkina T, Katcoff DJ and Malik Z: Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma. Br J Cancer (2004) 90: 1833-1841
10. Yamamoto F, Ohgari Y, Yamaki N, Kitajima S, Shimokawa O Matsui H and Taketani S: The role of nitric oxide in delta-aminole¬vulinic acid (ALA)-induced photosensitivity of cancerous cells. Biochem Biophys Res Commun (2007) 353: 541-546.
11. Okimura Y, Fujita H, Ogino T, Inoue K, Shuin T, Yano H Yasuda T, Inoue M, Utsumi K and Sasaki J: Regulation of 5-ami¬nolevulinic acid-dependent protoporphyrin IX accumulations in human histiocytic lymphoma U937 cells. Physiol Chem Phys Med NMR (2007) 39: 69-82
12. Frank J, Lornejad-Schäfer MR, Schöffl H, Flaccus A, Lambert C and Biesalski HK: Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int J Oncol (2007) 31: 1539-1545.
13. Krishnamurthy P, Xie T and Schuetz JD: The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther (2007) 114: 345-358.
14. Susanto J, Lin YH, Chen YN, Shen CR, Yan YT, Tsai ST, Chen CH and Shen CN: Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells. (2008) PLoS One 3: e4023.
15. Zutz A, Gompf S, Schägger H and Tampé R: Mitochondrial ABC proteins in health and disease. Biochim Biophys Acta (2009) 1787: 681-690.
16. Robey RW, Steadman K, Polgar O and Bates SE: ABCG2-mediated transport of photosensitizers: potential impact on photo¬dynamic therapy. Cancer Biol Ther (2005) 4: 187-194
17. White MJ, Miller FN, Heuser LS and Pietsch CG: Human malig¬nant ascites and histamine-induced protein leakage from the nor¬mal microcirculation. Microvasc Res (1988) 35: 63-72
18. Ogino T, Kobuchi H, Munetomo K, Fujita H, Yamamoto M Utsumi T, Inoue K, Shuin T, Sasaki J, Inoue M and Utsumi K: Serum-dependent export of protoporphyrin IX by ATP-binding cas¬sette transporter G2 in T24 cells. Mol Cell Biochem (2011) 358 297-307.
19. Grebenová D, Kuzelová K, Smetana K, Pluskalová M Cajthamlová H, Marinov I, Fuchs O, Soucek J, Jarolím P and Hrkal Z: Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells. J Photochem Photobiol B (2003) 69: 71-85.
20. Kuzelová K, Grebenová D, Pluskalová M, Marinov I and Hrkal Z: Early apoptotic features of K562 cell death induced by 5-aminolae¬vulinic acid-based photodynamic therapy. J Photochem Photobiol B (2004) 73: 67-78.
21. Kriska T, Korytowski W and Girotti AW: Role of mitochondrial car-diolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. Arch Biochem Biophys (2005) 433: 435-446.
22. Inoue K, Karashima T, Kamada M, Shuin T, Kurabayashi A, Furihata M, Fujita H, Utsumi K and Sasaki J: Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Pathobiology (2009) 76: 303-314.
23. Amo T, Kawanishi N, Uchida M, Fujita H, Oyanagi E, Utsumi T, Ogino T, Inoue K, Shuin T, Utsumi K and Sasaki J: Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histio¬cytic lymphoma cell line U937. Cell Biochem Funct (2009) 27 503-515.
24. Jacobson J, Duchen MR and Heales SJ: Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mito¬chondrial membrane potential: implications for assays of cardio-lipin and mitochondrial mass. J Neurochem (2002) 82: 224-233.
25. Sakharov DV, Elstak ED and Chernyak B: Prolonged lipid oxida¬tion after photodynamic treatment. Study with oxidation-sensitive probe C11-BODIPY581/591. FEBS Lett (2005) 579: 1255-1260
26. Soh N, Ariyoshi T, Fukaminato T, Nakajima H, Nakano K and mato T: Swallow-tailed perylene derivative: a new tool for fluores¬cent imaging of lipid hydroperoxides. Org Biomol Chem (2007) 5 3762-3768.
27. Liu YL, Ang SO, Weigent DA Prchal JT and Bloomer JR: Regulation of ferrochelatase gene expression by hypoxia. Life Sci (2004) 75: 2035-2043.
28. Furukawa T, Wakabayashi K, Tamura A, Nakagawa H, Morishima Y, Osawa Y and Ishikawa T: Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations. Pharm Res (2009) 26: 469-479.
29. Gewin L and Galloway DA: E box-dependent activation of telom-erase by human papillomavirus type 16 E6 does not require induc¬tion of c-myc. J Virol (2001) 75: 7198-7201
30. Laborda J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res (1991) 19: 3998.
31. Evseenko DA, Murthi P, Paxton JW, Reid G, Emerald BS Mohankumar KM, Lobie PE, Brennecke SP, Kalionis B and Keelan JA: The ABC transporter BCRP/ABCG2 is a placental sur¬vival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J (2007) 21: 3592-3605.
32. Juzenas P, Juzeniene A and Moan J: Deferoxamine photosensi¬tizes cancer cells in vitro. Biochem Biophys Res Commun (2005) 332: 388-391.
33. Ding Y, Lin B and Huie CW: Binding studies of porphyrins to human serum albumin using affinity capillary electrophoresis. Electrophoresis (2001) 22: 2210-2216.
34. Solazzo M, Fantappiè O, D'Amico M, Sassoli C, Tani A, Cipriani G, Bogani C, Formigli L and Mazzanti R: Mitochondrial expres¬sion and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res (2009) 69 7235-7242.
35. Sharma S, Jajoo A and Dube A: 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B (2007) 88: 156-162.
36. Wyld L, Burn JL, Reed MW and Brown NJ: Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br J Cancer (1997) 76: 705-712
37. Schoenfeld N, Mamet R, Nordenberg Y, Shafran M, Babushkin T and Malik Z: Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers characterization of photodynamic inactivation. Int J Cancer (1994) 56: 106-112.
38. Fukuda H, Batlle AM and Riley PA: Kinetics of porphyrin accumu¬lation in cultured epithelial cells exposed to ALA. Int J Biochem (1993) 25: 1407-1410.
39. Cosserat-Gerardin I, Bezdetnaya L, Notter D, Vigneron C and Guillemin F: Biosynthesis and photodynamic efficacy of protopor- phyrin IX (PplX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells. J Photochem Photobiol B (2000) 59: 72-79.
40. Selbo PK, Kaalhus O and Sivam G: 5-Aminolevulinic acid-based photochemical internalization of the immunotoxin MOC31-gelonin generates synergistic cytotoxic effects in vitro. Photochem Photobiol (2001) 74: 303-310.
41. Zhou S, Zong Y, Ney PA, Nair G, Stewart CF and Sorrentino BP: Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX lev¬els. Blood (2005) 105: 2571-2576.
42. Desuzinges-Mandon E, Arnaud O, Martinez L, Huché F, Di Pietro A and Falson P: ABCG2 transports and transfers heme to albumin through its large extracellular loop. J Biol Chem (2010) 285 33123-33133.
43. Chen HM, Liu CM, Yang H, Chou HY, Chiang CP and Kuo MY: 5-aminolevulinic acid induce apoptosis via NF-KB/JNK path¬way in human oral cancer Ca9-22 cells. J Oral Pathol Med (2011) 40: 483-489.
44. Furre IE, Møller MT, Shahzidi S Nesland JM and Peng Q: hvolvement of both caspase-dependent and -independent path¬ways in apoptotic induction by hexaminolevulinate-mediated photo¬dynamic therapy in human lymphoma cells. Apoptosis (2006) 11 2031-2042.
45. Ji HT, Chien LT, Lin YH, Chien HF and Chen CT: 5-ALA medi¬ated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase. Mol Cancer (2010) 9: 91
46. Gottlieb E, Vander H MG and Thompson CB: Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and sub¬sequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol (2000) 20: 5680-5689.
47. Karthein R, Dietz R, Nastainczyk W, and Ruf HH: Higher oxida¬tion states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction. Eur J Biochem (1988) 171: 313-320.
48. Akita Y, Kozaki K, Nakagawa A, Saito T, Ito S, Tamada Y, Fujiwara S, Nishikawa N, Uchida K, Yoshikawa K, Noguchi T, Miyaishi O, Shimozato K, Saga S and Matsumoto Y: Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity. Br J Dermatol (2004) 151: 472-480.